Table 1. Baseline characteristics of study participants.
| Total n=204 | With sarcopenia n=123 |
Without sarcopenia n=81 |
P | |
| Age (years) | 74.1 (8.2) | 74.6 (9.5) | 72.27 (10.9) | 0.183a |
| Sex male n (%) | 109 (53.4) | 61 (49.6) | 48 (59.3) | 0.198b |
| Stroke type n (%) Cerebral infarction Cerebral hemorrhage Subarachnoid hemorrhage |
127 (62.3) 62 (30.4) 15 (7.4) |
75 (61.0) 40 (32.5) 8 (6.5) |
52 (64.2) 22 (27.2) 7 (8.6) |
0.664b |
| Time from onset to admission (days) | 14 [9–19] | 15 [9–22] | 13 [10–21] | 0.499c |
| Stroke history n (%) | 53 (26.0) | 40 (32.5) | 13 (16.0) | 0.009b |
| Premorbid mRS | 0 [0–2] | 0 [0–2] | 0 [0–0] | 0.001c |
| Paralysis n (%) Right hemiplegia Left hemiplegia Bilateral hemiplegia |
83 (40.7) 79 (38.7) 12 (5.9) |
49 (39.8) 47 (38.2) 11 (8.9) |
34 (42.0) 32 (39.5) 1 (1.2) |
0.664b |
| Brunnstrom Stage | 5 [2–6] | 4 [2–6] | 5 [3–6] | 0.01c |
| Charlson Comorbidity Index | 3 [2–4] | 3 [3–5] | 3 [2–4] | 0.034 |
| Food Intake LEVEL Scale | 7 [6–9] | 7 [2–9] | 9 [7–10] | <0.001c |
| BMI (kg/m2) | 22.1 (2.5) | 20.79 (2.7) | 24.1 (3.2) | <0.001a |
| SMI (kg/m2) | 6.1 (1.3) | 5.33 (1.0) | 7.17 (0.8) | <0.001a |
| Handgrip strength (kg) | 16.4 (6.1) | 12.27 (6.4) | 22.60 (8.7) | <0.001a |
| MNA-SF | 6 [4–9] | 5 [4–8] | 9 [7–10] | <0.001c |
| FIM Motor Cognitive Total |
38.1 (12.1) 19.2 (8.2) 57.1 (16.2) |
32.6 (11.0) 17.6 (8.6) 50.5 (20.3) |
45.6 (13.0) 21.6 (8.5) 67.4 (19.4) |
<0.001a
0.001a <0.001a |
| mGPS score n (%) 0 1 2 |
151 (74.0) 40 (19.6) 13 (6.4) |
70 (56.9) 33 (26.8) 20 (16.3) |
61 (75.3) 12 (14.8) 8 (9.9) |
0.041b |
| Laboratory data Alb (g/dL) Hb (g/dL) CRP (mg/dL) |
3.5 (0.5) 13.1 (1.8) 1.3 (0.7) |
3.4 (0.6) 12.8 (1.7) 1.4 (1.1) |
3.6 (0.5) 13.61 (1.88) 1.0 (0.9) |
0.015a
0.254a 0.002a |
Data are expressed as means (standard deviation), medians [interquartile range], or n (%).
at-test, bChi-square test, cMann-Whitney U test.